Clinical antiviral efficacy of favipiravir in early COVID-19 (PLATCOV): an open-label, randomised, controlled, adaptive platform trial
Description
In early symptomatic COVID-19 treatment, high dose oral favipiravir did not accelerate viral clearance.
